It was reported during unspecified time after starting treatment with a revaclear 300, the patient experienced "nausea, vomiting and severe abdominal pain".Blood pressure at the time of the event was 197/102 mmhg and spo2 was 78%.The patient was provided with oxygen, nifedipine sublingual and atropine 0.5mg intramuscular injection.Blood sampling for cardiac biomarkers and bedside electrocardiogram were performed (no results provided).The extracorporeal (ec) blood was returned, and the symptoms reportedly subsided after half an hour.No additional information is available.
|
H10: a batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
|